Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


17.09.2018

5 AIDS
6 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
4 Clin Infect Dis
1 Dermatology
1 Int J Cancer
20 J Acquir Immune Defic Syndr
2 J Clin Invest
1 J Infect Dis
1 J Med Virol
3 J Virol
3 JAMA
1 Lancet
10 Lancet HIV
1 Lancet Infect Dis
1 Lancet Public Health
1 MMWR Morb Mortal Wkly Rep
1 Nat Med
1 Nature
6 Pediatr Infect Dis J
1 Pediatrics
15 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. SHADE SB, Osmand T, Luo A, Aine R, et al
    Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001958.
    PubMed     Text format     Abstract available

  2. JILG N, Hunt PW, Gandhi RT
    HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort study.
    AIDS. 2018;32:2255-2257.
    PubMed     Text format    


  3. High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years: Erratum.
    AIDS. 2018;32:2267.
    PubMed     Text format    

  4. NORET M, Balavoine S, Pintado C, Siguier M, et al
    Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France.
    AIDS. 2018;32:2161-2169.
    PubMed     Text format     Abstract available

  5. KOSS CA, Liu AY, Castillo-Mancilla J, Bacchetti P, et al
    Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring.
    AIDS. 2018;32:2189-2194.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  6. HANSEN SS, Kronborg G, Benfield T
    Prediction of liver disease, AIDS and mortality based on discordant absolute and relative peripheral CD4 T lymphocytes in HIV/HCV co-infected individuals.
    AIDS Res Hum Retroviruses. 2018 Sep 11. doi: 10.1089/AID.2017.0058.
    PubMed     Text format     Abstract available

  7. HANSOTI B, Stead D, Eisenberg A, Mvandaba N, et al
    A Window into the HIV epidemic from a South African Emergency Department.
    AIDS Res Hum Retroviruses. 2018 Sep 14. doi: 10.1089/AID.2018.0127.
    PubMed     Text format     Abstract available

  8. EISENBERG AL, Patel EU, Packman Z, Fernandez R, et al
    Dried blood spots stored at room temperature should not be used for HIV incidence testing.
    AIDS Res Hum Retroviruses. 2018 Sep 14. doi: 10.1089/AID.2018.0138.
    PubMed     Text format     Abstract available

  9. SAENG-AROON S, Saipradit N, Loket R, Klamkhai N, et al
    External Quality Assessment Scheme for HIV-1 Drug Resistance Genotyping in Thailand.
    AIDS Res Hum Retroviruses. 2018 Sep 14. doi: 10.1089/AID.2017.0299.
    PubMed     Text format     Abstract available

  10. BACHTEL ND, Beckerle GA, Mota T, Rougvie MM, et al
    Expression of host restriction factors by memory CD4+ T cells differs between healthy donors and HIV-1 infected individuals with effective ART.
    AIDS Res Hum Retroviruses. 2018 Sep 10. doi: 10.1089/AID.2018.0162.
    PubMed     Text format     Abstract available

  11. NOWAK RG, Bentzen SM, Ravel J, Crowell T, et al
    Anal microbial patterns and oncogenic HPV in a pilot study of Nigerian men who have sex with men at risk for or living with HIV.
    AIDS Res Hum Retroviruses. 2018 Sep 14. doi: 10.1089/AID.2018.0158.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  12. GOMES A, Ferraz R, Ficker L, Collins MS, et al
    Chloroquine analogues as leads against Pneumocystis lung pathogens.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.00983.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  13. GOETGHEBUER T, Smolen KK, Adler C, Das J, et al
    Initiation of anti-retroviral therapy before pregnancy reduces the risk of infection-related hospitalization in HIV-exposed uninfected infants born in a high-income country.
    Clin Infect Dis. 2018 Sep 12. pii: 5095730. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. HAMMOUD DA, Boulougoura A, Papadakis GZ, Wang J, et al
    Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Human Immunodeficiency Virus-Associated Immune Reconstitution Inflammatory Syndrome.
    Clin Infect Dis. 2018 Sep 11. pii: 5095310. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. LUPO J, Germi R, Costagliola D, Morand P, et al
    Utility of Epstein-Barr Virus biomarkers in HIV-related lymphomas in the modern combined antiretroviral therapy era.
    Clin Infect Dis. 2018 Sep 11. pii: 5094805. doi: 10.1093.
    PubMed     Text format    

  16. CHAMBERS LC, Srinivasan S, Lukehart SA, Ocbamichael N, et al
    Primary Syphilis in the Male Urethra - A Case Report.
    Clin Infect Dis. 2018 Sep 10. pii: 5094508. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dermatology

  17. TOUNOUGA DN, Kouotou EA, Nansseu JR, Zoung-Kanyi Bissek AC, et al
    Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaounde, Cameroon.
    Dermatology. 2018 Sep 11:1-7. doi: 10.1159/000492175.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. EL-MALLAWANY NK, Mehta PS, Kamiyango W, Villiera J, et al
    KSHV Viral Load and Interleukin-6 in HIV-Associated Pediatric Kaposi Sarcoma-Exploring the Role of Lytic Activation in Driving the Unique Clinical Features Seen in Endemic Regions.
    Int J Cancer. 2018 Sep 11. doi: 10.1002/ijc.31863.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  19. YUENGLING KA, Padayatchi N, Wolf A, Mathema B, et al
    Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug Resistant Tuberculosis (XDR-TB) HIV Co-Infection Treatment in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2018 Sep 11. doi: 10.1097/QAI.0000000000001833.
    PubMed     Text format     Abstract available

  20. THURMAN A, Schwartz JL, Brache V, Chen BA, et al
    The Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate users.
    J Acquir Immune Defic Syndr. 2018 Sep 11. doi: 10.1097/QAI.0000000000001864.
    PubMed     Text format     Abstract available

  21. YEN YF, Feng JY, Yi-Fong Su V, Chuang PH, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Uveitis Among People Living With HIV/AIDS.
    J Acquir Immune Defic Syndr. 2018;79:149-157.
    PubMed     Text format     Abstract available

  22. RONIT A, Ahlstrom MG, Knudsen AD, Gerstoft J, et al
    HIV Status Is a Greater Determinant of Low Self-perceived Life Expectancy Than Cigarette Smoking in a Well-resourced Setting.
    J Acquir Immune Defic Syndr. 2018;79:e81-e84.
    PubMed     Text format    

  23. O'CLEIRIGH C, Zvolensky MJ, Smits JAJ, Labbe AK, et al
    Integrated Treatment for Smoking Cessation, Anxiety, and Depressed Mood in People Living With HIV: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2018;79:261-268.
    PubMed     Text format     Abstract available

  24. GREENHALGH S, Hobbs CV, Parikh S
    Brief Report: Antimalarial Benefit of HIV Antiretroviral Therapy in Areas of Low to Moderate Malaria Transmission Intensity.
    J Acquir Immune Defic Syndr. 2018;79:249-254.
    PubMed     Text format     Abstract available

  25. CHINTANAPHOL M, Sacdalan C, Chottanapund S, Pinyakorn S, et al
    Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in Thailand.
    J Acquir Immune Defic Syndr. 2018;79:244-248.
    PubMed     Text format     Abstract available

  26. NKHOMA K, Norton C, Sabin C, Winston A, et al
    Self-management Interventions for Pain and Physical Symptoms Among People Living With HIV: A Systematic Review of the Evidence.
    J Acquir Immune Defic Syndr. 2018;79:206-225.
    PubMed     Text format     Abstract available

  27. ROUX P, Fressard L, Suzan-Monti M, Chas J, et al
    Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial.
    J Acquir Immune Defic Syndr. 2018;79:e69-e75.
    PubMed     Text format     Abstract available

  28. MCMAHON BA, Hanouneh M, Chedid A, Fine DM, et al
    Association of HIV Suppression with Kidney Disease Progression among HIV-Positive African Americans with Biopsy-Proven Classic FSGS.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001860.
    PubMed     Text format     Abstract available

  29. PINTYE J, Kinuthia J, Roberts DA, Wagner AD, et al
    Integration of PrEP Services Into Routine Antenatal and Postnatal care: Experiences from an Implementation Program in Western Kenya.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001850.
    PubMed     Text format     Abstract available

  30. MUCCINI C, Galli L, Poli A, Carbone A, et al
    Hyperbilirubinemia is Associated with A Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients On Virological Suppression.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001854.
    PubMed     Text format     Abstract available

  31. DHANDE J, Angadi M, Murugavel KG, Poongulali S, et al
    Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
    J Acquir Immune Defic Syndr. 2018;79:277-282.
    PubMed     Text format     Abstract available

  32. NARLA V, Bhakta N, Freedman JE, Tanriverdi K, et al
    Unique Circulating MicroRNA profiles in HIV Infection.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001851.
    PubMed     Text format     Abstract available

  33. PARENT S, Barrios R, Nosyk B, Ye M, et al
    The Impact Of Patient-Provider Attachment On Hospital Readmissions Among People Living With Hiv: A Population-Based Study.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001857.
    PubMed     Text format     Abstract available

  34. NWANGWU-IKE N, Frazier EL, Crepaz N, Tie Y, et al
    Racial and Ethnic Differences in Viral Suppression Among HIV-Positive Women in Care.
    J Acquir Immune Defic Syndr. 2018;79:e56-e68.
    PubMed     Text format     Abstract available

  35. KAPOGIANNIS BG, Nelson RM, Siberry GK, Lee S, et al
    Advancing HIV Biomedical Prevention Research for At-Risk Adolescents.
    J Acquir Immune Defic Syndr. 2018 Sep 4. doi: 10.1097/QAI.0000000000001853.
    PubMed     Text format     Abstract available

  36. GROVER S, Desir F, Jing Y, Bhatia RK, et al
    Reduced cancer survival among adults with HIV and an AIDS-defining illnesses despite no difference in cancer stage at diagnosis.
    J Acquir Immune Defic Syndr. 2018 Sep 5. doi: 10.1097/QAI.0000000000001842.
    PubMed     Text format     Abstract available

  37. SADOH A, Eki-Udoko FE
    Cotransmission of Malaria and HIV to Infants of Mothers Coinfected With Malaria and HIV in the HAART Era in Benin City, Nigeria.
    J Acquir Immune Defic Syndr. 2018;79:255-260.
    PubMed     Text format     Abstract available

  38. TAGARRO A, Chan M, Zangari P, Ferns B, et al
    Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children.
    J Acquir Immune Defic Syndr. 2018;79:269-276.
    PubMed     Text format     Abstract available


    J Clin Invest

  39. KANDATHIL AJ, Sugawara S, Goyal A, Durand CM, et al
    No recovery of replication-competent HIV-1 from human liver macrophages.
    J Clin Invest. 2018 Sep 10. pii: 121678. doi: 10.1172/JCI121678.
    PubMed     Text format     Abstract available

  40. SIVANANDHAM R, Brocca-Cofano E, Krampe N, Falwell E, et al
    Neutrophil extracellular trap production contributes to pathogenesis in SIV-infected nonhuman primates.
    J Clin Invest. 2018 Sep 11. pii: 99420. doi: 10.1172/JCI99420.
    PubMed     Text format     Abstract available


    J Infect Dis

  41. KEHRMANN J, Menzel J, Saeedghalati M, Obeid R, et al
    Gut microbiota in HIV-infected individuals linked to coronary heart disease.
    J Infect Dis. 2018 Sep 7. pii: 5092661. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  42. ROLDAN EQ, Properzi M, Amadasi S, Raffetti E, et al
    Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of Hepatocellular carcinoma (HCC): a single-centre study.
    J Med Virol. 2018 Sep 14. doi: 10.1002/jmv.25317.
    PubMed     Text format     Abstract available


    J Virol

  43. PISSANI F, Schulte B, Eller MA, Schultz BT, et al
    Modulation of Vaccine-induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    J Virol. 2018 Sep 12. pii: JVI.01143-18. doi: 10.1128/JVI.01143.
    PubMed     Text format     Abstract available

  44. REN Y, Korom M, Truong R, Chan D, et al
    Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs.
    J Virol. 2018 Sep 12. pii: JVI.00895-18. doi: 10.1128/JVI.00895.
    PubMed     Text format     Abstract available

  45. MACDUFF DA, Baldridge MT, Qaqish AM, Nice TJ, et al
    HOIL1 is essential for the induction of type I and III interferons by MDA5 and regulates persistent murine norovirus infection.
    J Virol. 2018 Sep 12. pii: JVI.01368-18. doi: 10.1128/JVI.01368.
    PubMed     Text format     Abstract available


    JAMA

  46. HARRIS PNA, Tambyah PA, Lye DC, Mo Y, et al
    Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    JAMA. 2018;320:984-994.
    PubMed     Text format     Abstract available

  47. KUEHN B
    Gaps in HIV Testing for Black Men.
    JAMA. 2018;320:966.
    PubMed     Text format    

  48. ABBASI J
    HIV Preexposure Prophylaxis "Smart Pill" in Early Testing.
    JAMA. 2018;320:965.
    PubMed     Text format    


    Lancet

  49. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Text format     Abstract available


    Lancet HIV

  50. HAMERS RL, Rinke de Wit TF, Holmes CB
    HIV drug resistance in low-income and middle-income countries.
    Lancet HIV. 2018 Sep 4. pii: S2352-3018(18)30173.
    PubMed     Text format     Abstract available

  51. HAYWARD P
    Highlights of AIDS 2018.
    Lancet HIV. 2018;5:e485.
    PubMed     Text format    

  52. BURKI T
    Scotland's struggle with injection drug use and HIV.
    Lancet HIV. 2018;5:e483-e484.
    PubMed     Text format    

  53. CARVETH-JOHNSON T, Stingone C, Nwokolo N, Whitlock G, et al
    Doxycycline use in MSM taking PrEP.
    Lancet HIV. 2018;5:e482.
    PubMed     Text format    

  54. CHOW EPF, Medland NA, Denham I, Wright EJ, et al
    Decline in new HIV diagnoses among MSM in Melbourne.
    Lancet HIV. 2018;5:e479-e481.
    PubMed     Text format    

  55. THE LANCET HIV
    HIV criminalisation is bad policy based on bad science.
    Lancet HIV. 2018;5:e473.
    PubMed     Text format    

  56. TANG W, Wu D
    Opportunities and challenges for HIV self-testing in China.
    Lancet HIV. 2018 Sep 10. pii: S2352-3018(18)30244.
    PubMed     Text format    

  57. SPAULDING AC, Holstad MM
    Lessons from HIV deaths after incarceration.
    Lancet HIV. 2018 Sep 6. pii: S2352-3018(18)30218.
    PubMed     Text format    

  58. LOELIGER KB, Altice FL, Ciarleglio MM, Rich KM, et al
    All-cause mortality among people with HIV released from an integrated system of jails and prisons in Connecticut, USA, 2007-14: a retrospective observational cohort study.
    Lancet HIV. 2018 Sep 6. pii: S2352-3018(18)30175.
    PubMed     Text format     Abstract available

  59. BURKI T
    Glasgow Drugs Crisis Centre providing a safe environment.
    Lancet HIV. 2018;5:e486.
    PubMed     Text format    


    Lancet Infect Dis

  60. DIVALA TH, Mungwira RG, Mawindo PM, Nyirenda OM, et al
    Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
    Lancet Infect Dis. 2018 Sep 5. pii: S1473-3099(18)30415.
    PubMed     Text format     Abstract available


    Lancet Public Health

  61. SOLDAN K, Dunbar JK, Gill ON
    Estimating chlamydia prevalence: more difficult than modelling suggests.
    Lancet Public Health. 2018;3:e416.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  62. RASBERRY CN, Lowry R, Johns M, Robin L, et al
    Sexual Risk Behavior Differences Among Sexual Minority High School Students - United States, 2015 and 2017.
    MMWR Morb Mortal Wkly Rep. 2018;67:1007-1011.
    PubMed     Text format     Abstract available


    Nat Med

  63. STOWER H
    An option for treatment of multidrug-resistant HIV.
    Nat Med. 2018;24:1303.
    PubMed     Text format    


    Nature

  64. KOUYOS RD, Rusert P, Kadelka C, Huber M, et al
    Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.
    Nature. 2018 Sep 10. pii: 10.1038/s41586-018-0517.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  65. FIDLER K, Foster C, Lim EJ, Patel A, et al
    Reactivity of Routine HIV Antibody Tests in Children with Perinatally-Acquired HIV-1 in England: Cross Sectional Analysis.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002143.
    PubMed     Text format     Abstract available

  66. FARNAES L, Coufal N, Spector SA
    Vaccine Strain Varicella Infection in an Infant with Previously Undiagnosed Perinatal Human Immunodeficiency Type-1 Infection.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002183.
    PubMed     Text format     Abstract available

  67. AYIEKO J, Chamie G, Balzer L, Kwarisiima D, et al
    Mobile, Population-Wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda.
    Pediatr Infect Dis J. 2018 Sep 7. doi: 10.1097/INF.0000000000002142.
    PubMed     Text format     Abstract available

  68. ANUGULRUENGKITT S, Cressey TR, Suntarattiwong P, Ounchanum P, et al
    Nevirapine Concentrations During the First Month of Life And Maternal Efavirenz Washout in High Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis.
    Pediatr Infect Dis J. 2018 Sep 10. doi: 10.1097/INF.0000000000002195.
    PubMed     Text format     Abstract available

  69. ADACHI K, Xu J, Ank B, Watts DH, et al
    Congenital Cytomegalovirus and HIV Perinatal Transmission.
    Pediatr Infect Dis J. 2018;37:1016-1021.
    PubMed     Text format     Abstract available

  70. SIGAUQUE B, Moiane B, Massora S, Pimenta F, et al
    Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Pediatr Infect Dis J. 2018;37:1054-1060.
    PubMed     Text format     Abstract available


    Pediatrics

  71. HINES L, Glick J, Bilka K, Lantos JD, et al
    Medical Marijuana for Minors May Be Considered Child Abuse.
    Pediatrics. 2018 Sep 13. pii: peds.2017-4310. doi: 10.1542/peds.2017-4310.
    PubMed     Text format     Abstract available


    PLoS One

  72. PANTAZIS N, Chini M, Antoniadou A, Sambatakou H, et al
    The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort.
    PLoS One. 2018;13:e0203601.
    PubMed     Text format     Abstract available

  73. HADDAD LB, Brown JL, King C, Gause NK, et al
    Contraceptive, condom and dual method use at last coitus among perinatally and horizontally HIV-infected young women in Atlanta, Georgia.
    PLoS One. 2018;13:e0202946.
    PubMed     Text format     Abstract available

  74. WARE D, Palella FJ Jr, Chew KW, Friedman MR, et al
    Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016.
    PLoS One. 2018;13:e0203890.
    PubMed     Text format     Abstract available

  75. MADEIRA DE OLIVEIRA S, Altmayer S, Zanon M, Alves Sidney-Filho L, et al
    Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America.
    PLoS One. 2018;13:e0202593.
    PubMed     Text format     Abstract available

  76. PITPITAN EV, Semple SJ, Aarons GA, Palinkas LA, et al
    Factors associated with program effectiveness in the implementation of a sexual risk reduction intervention for female sex workers across Mexico: Results from a randomized trial.
    PLoS One. 2018;13:e0201954.
    PubMed     Text format     Abstract available

  77. ALEMU YM, Habtewold TD, Alemu SM
    Mother's knowledge on prevention of mother-to-child transmission of HIV, Ethiopia: A cross sectional study.
    PLoS One. 2018;13:e0203043.
    PubMed     Text format     Abstract available

  78. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Influence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia.
    PLoS One. 2018;13:e0203121.
    PubMed     Text format     Abstract available

  79. GREBE E, Welte A, Johnson LF, van Cutsem G, et al
    Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa.
    PLoS One. 2018;13:e0203638.
    PubMed     Text format     Abstract available

  80. BWANA P, Ochieng' L, Mwau M
    Performance and usability evaluation of the INSTI HIV self-test in Kenya for qualitative detection of antibodies to HIV.
    PLoS One. 2018;13:e0202491.
    PubMed     Text format     Abstract available

  81. WERNER RN, Gaskins M, Ahrens J, Jessen H, et al
    Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin - A multicentre, cross-sectional survey.
    PLoS One. 2018;13:e0204067.
    PubMed     Text format     Abstract available

  82. MENDOZA Y, Garcia-Morales C, Bello G, Garrido-Rodriguez D, et al
    Evolutionary history and spatiotemporal dynamics of the HIV-1 subtype B epidemic in Guatemala.
    PLoS One. 2018;13:e0203916.
    PubMed     Text format     Abstract available

  83. MATHUR S, Okal J, Musheke M, Pilgrim N, et al
    High rates of sexual violence by both intimate and non-intimate partners experienced by adolescent girls and young women in Kenya and Zambia: Findings around violence and other negative health outcomes.
    PLoS One. 2018;13:e0203929.
    PubMed     Text format     Abstract available

  84. REYNOLDS Z, Gottert A, Luben E, Mamba B, et al
    Who are the male partners of adolescent girls and young women in Swaziland? Analysis of survey data from community venues across 19 DREAMS districts.
    PLoS One. 2018;13:e0203208.
    PubMed     Text format     Abstract available

  85. MOHR E, Snyman L, Mbakaz Z, Caldwell J, et al
    "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.
    PLoS One. 2018;13:e0203888.
    PubMed     Text format     Abstract available

  86. TLOU B
    Underlying determinants of maternal mortality in a rural South African population with high HIV prevalence (2000-2014): A population-based cohort analysis.
    PLoS One. 2018;13:e0203830.
    PubMed     Text format     Abstract available


    Vaccine

  87. ELBAHNASAWY MA, Donius LR, Reinherz EL, Kim M, et al
    Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses.
    Vaccine. 2018 Sep 6. pii: S0264-410X(18)31123.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: